Literature DB >> 32902550

Connecting the conformational behavior of cyclic octadepsipeptides with their ionophoric property and membrane permeability.

Thomas Stadelmann1, Govindan Subramanian2, Sanjay Menon2, Chad E Townsend3, R Scott Lokey3, Marc-Olivier Ebert1, Sereina Riniker1.   

Abstract

Cyclic octadepsipeptides such as PF1022A and its synthetic derivative emodepside exhibit anthelmintic activity with the latter sold as a commercial drug treatment against gastrointestinal nematodes for animal health use. The structure-permeability relationship of these cyclic depsipeptides that could ultimately provide insights into the compound bioavailability is not yet well understood. The fully N-methylated amide backbone and apolar sidechain residues do not allow for the formation of intramolecular hydrogen bonds, normally observed in the membrane-permeable conformations of cyclic peptides. Hence, any understanding gained on these depsipeptides would serve as a prototype for future design strategies. In previous nuclear magnetic resonance (NMR) studies, two macrocyclic core conformers of emodepside were detected, one with all backbone amides in trans-configuration (hereon referred as the symmetric conformer) and the other with one amide in cis-configuration (hereon referred as the asymmetric conformer). In addition, these depsipeptides were also reported to be ionophores with a preference of potassium over sodium. In this study, we relate the conformational behavior of PF1022A, emodepside, and closely related analogs with their ionophoric characteristic probed using NMR and molecular dynamics (MD) simulations and finally evaluated their passive membrane permeability using PAMPA. We find that the equilibrium between the two core conformers shifts more towards the symmetric conformer upon addition of monovalent cations with selectivity for potassium over sodium. Both the NMR experiments and the theoretical Markov state models based on extensive MD simulations indicate a more rigid backbone for the asymmetric conformation, whereas the symmetric conformation shows greater flexibility. The experimental results further advocate for the symmetric conformation binding the cation. The PAMPA results suggest that the investigated depsipeptides are retained in the membrane, which may be advantageous for the likely target, a membrane-bound potassium channel.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32902550      PMCID: PMC7796559          DOI: 10.1039/d0ob01447h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  59 in total

1.  Determining association constants from titration experiments in supramolecular chemistry.

Authors:  Pall Thordarson
Journal:  Chem Soc Rev       Date:  2010-12-01       Impact factor: 54.564

2.  GROMOS++ Software for the Analysis of Biomolecular Simulation Trajectories.

Authors:  Andreas P Eichenberger; Jane R Allison; Jožica Dolenc; Daan P Geerke; Bruno A C Horta; Katharina Meier; Chris Oostenbrink; Nathan Schmid; Denise Steiner; Dongqi Wang; Wilfred F van Gunsteren
Journal:  J Chem Theory Comput       Date:  2011-09-16       Impact factor: 6.006

3.  Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.

Authors:  Matthew R Naylor; Andrew M Ly; Mason J Handford; Daniel P Ramos; Cameron R Pye; Akihiro Furukawa; Victoria G Klein; Ryan P Noland; Quinn Edmondson; Alexandra C Turmon; William M Hewitt; Joshua Schwochert; Chad E Townsend; Colin N Kelly; Maria-Jesus Blanco; R Scott Lokey
Journal:  J Med Chem       Date:  2018-12-11       Impact factor: 7.446

4.  Markov models of molecular kinetics: generation and validation.

Authors:  Jan-Hendrik Prinz; Hao Wu; Marco Sarich; Bettina Keller; Martin Senne; Martin Held; John D Chodera; Christof Schütte; Frank Noé
Journal:  J Chem Phys       Date:  2011-05-07       Impact factor: 3.488

5.  Markov state models based on milestoning.

Authors:  Christof Schütte; Frank Noé; Jianfeng Lu; Marco Sarich; Eric Vanden-Eijnden
Journal:  J Chem Phys       Date:  2011-05-28       Impact factor: 3.488

6.  Definition and testing of the GROMOS force-field versions 54A7 and 54B7.

Authors:  Nathan Schmid; Andreas P Eichenberger; Alexandra Choutko; Sereina Riniker; Moritz Winger; Alan E Mark; Wilfred F van Gunsteren
Journal:  Eur Biophys J       Date:  2011-04-30       Impact factor: 1.733

7.  Effects on MC3T3-E1 Cells and In silico Toxicological Study of Two 6-(Propan-2-yl)-4-methyl-morpholine-2,5-diones.

Authors:  Marija Vukelić-Nikolić; Ana Kolarevć; Katarina Tomović; Denitsa Yancheva; Emiliya Cherneva; Stevo Najman; Andrija Smelcerović
Journal:  Nat Prod Commun       Date:  2015-08       Impact factor: 0.986

8.  Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis.

Authors:  S Elmshäuser; L C Straehle; J Kranz; R Krebber; J Geyer
Journal:  J Vet Pharmacol Ther       Date:  2014-08-01       Impact factor: 1.786

9.  Mechanisms of action of emodepside.

Authors:  A Harder; L Holden-Dye; R Walker; F Wunderlich
Journal:  Parasitol Res       Date:  2005-10       Impact factor: 2.289

10.  Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.

Authors:  Jagna Witek; Shuzhe Wang; Benjamin Schroeder; Robin Lingwood; Andreas Dounas; Hans-Jörg Roth; Marianne Fouché; Markus Blatter; Oliver Lemke; Bettina Keller; Sereina Riniker
Journal:  J Chem Inf Model       Date:  2018-12-04       Impact factor: 4.956

View more
  1 in total

1.  A Specialized Dehydrogenase Provides l-Phenyllactate for FR900359 Biosynthesis.

Authors:  Sophie Klöppel; René Richarz; Daniel A Wirtz; Natalia Vasenda; Gabriele M König; Max Crüsemann
Journal:  Chembiochem       Date:  2021-12-09       Impact factor: 3.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.